SHINPOONG PHARMACEUTICAL CO.,LTD
Develops and manufactures pharmaceuticals, APIs, and medical devices for global markets.
019170 | KO
Overview
Corporate Details
- ISIN(s):
- KR7019170000
- LEI:
- Country:
- South Korea
- Address:
- 경기도 안산시 단원구 원시로 7, 안산시
- Sector:
- Manufacturing
Description
SHINPOONG PHARMACEUTICAL CO.,LTD. is a research and development-oriented pharmaceutical company that manufactures and markets a wide range of pharmaceutical products and active pharmaceutical ingredients (APIs). The company's portfolio includes finished products such as cephalosporin and penicillin antibiotics, antivirals, anticancer drugs, and painkillers. It also develops and supplies medical devices, including Medicurtain, an anti-adhesion barrier. The company manages the entire production process from raw materials to finished goods, serving both domestic and international markets.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-07 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.3 KB | ||
| 2025-03-07 00:00 |
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
|
Korean | 23.7 KB | ||
| 2025-02-21 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변경
|
Korean | 14.5 KB | ||
| 2024-12-12 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 3.9 KB | ||
| 2024-11-14 00:00 |
분기보고서 (2024.09)
|
Korean | 1.5 MB | ||
| 2024-10-17 00:00 |
[기재정정]투자판단관련주요경영사항 (급성 허혈성 뇌졸중 치료제 SP8203 임상 3상 시험계획 승인)
|
Korean | 14.4 KB | ||
| 2024-10-15 00:00 |
투자판단관련주요경영사항 (급성 허혈성 뇌졸중 치료제 SP8203 임상 3상 시험계획 승인)
|
Korean | 10.5 KB | ||
| 2024-10-11 00:00 |
투자판단관련주요경영사항 (골관절염 주사요법제 SP5M002주의 임상 3상 시험변경계획승인)
|
Korean | 13.4 KB | ||
| 2024-09-19 00:00 |
[기재정정]횡령ㆍ배임사실확인
|
Korean | 15.6 KB | ||
| 2024-08-19 00:00 |
[기재정정]반기보고서 (2024.06)
|
Korean | 1.5 MB | ||
| 2024-08-14 00:00 |
반기보고서 (2024.06)
|
Korean | 1.5 MB | ||
| 2024-08-09 00:00 |
투자판단관련주요경영사항 (급성 허혈성 뇌졸중 치료제 SP8203 임상 3상 시험계획 승인 신청)
|
Korean | 9.8 KB | ||
| 2024-08-02 00:00 |
투자판단관련주요경영사항
|
Korean | 12.7 KB | ||
| 2024-07-22 00:00 |
횡령ㆍ배임사실확인
|
Korean | 8.6 KB | ||
| 2024-07-12 00:00 |
투자판단관련주요경영사항 (골관절염 주사요법제 SP5M001주의 품목허가승인)
|
Korean | 9.9 KB |
Automate Your Workflow. Get a real-time feed of all SHINPOONG PHARMACEUTICAL CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SHINPOONG PHARMACEUTICAL CO.,LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SHINPOONG PHARMACEUTICAL CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
